Overall rank by patents
#1,299
Across all tracked assignees
USPTO PatentsView assignee record - 326 granted patents across 34 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H01M (PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY).
The verdict
Ningde holds 326 US patents across 34 technology areas, rank #1,299 of 50,000 tracked assignees.
Ningde Amperex Technology Limited has been granted 326 US utility patents between 2015 and 2025, placing Ningde Amperex Technology Limited at rank #1,299 across all assignees tracked by PlainPatent. This portfolio spans 34 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.6 claims per patent with primary concentration in H01M (PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY). As a Foreign Corporation, Ningde Amperex Technology Limited is one of the more focused assignees in the PatentsView dataset. By volume, Ningde sits between Bayer Pharma Aktiengesellschaft (326 patents, rank #1,295) and Chugai Seiyaku Kabushiki Kaisha (325 patents, rank #1,303) - the closest US assignees by grant volume. The composite Innovation Score of 63.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 294 grants, compared with 32 in the 2015–2019 window, a +819% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ningde Amperex Technology Limited's 16.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 34 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ningde Amperex Technology Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Bayer Pharma Aktiengesellschaft
326 patents
HANGZHOU HIKVISION DIGITAL TECHNOLOGY CO., LTD.
326 patents
KLEMM + SOHN GMBH & CO. KG
326 patents
Littelfuse, Inc.
326 patents
SICK AG
326 patents
Sumitomo Riko Company Limited
326 patents
UNIVERSITY OF CONNECTICUT
326 patents
NINGDE AMPEREX TECHNOLOGY LIMITED
326 patents
CHUGAI SEIYAKU KABUSHIKI KAISHA
325 patents
What this shows Ningde holds 326 patents at rank #1,299, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,299 in granted patent volume.
Other assignees with the most granted patents in Ningde's primary technology class.
Ningde's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
64 Top 2% higher than 98% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 0.3% |
| 2016 | 2 | 0.6% |
| 2017 | 16 | 4.9% |
| 2018 | 2 | 0.6% |
| 2019 | 11 | 3.4% |
| 2020 | 21 | 6.4% |
| 2021 | 50 | 15.3% |
| 2022 | 40 | 12.3% |
| 2023 | 43 | 13.2% |
| 2024 | 77 | 23.6% |
| 2025 | 63 | 19.3% |
Top 15 of 34 technology areas
Overall rank by patents
#1,299
Across all tracked assignees
63.5 out of 100
How to use this portfolio
Ningde's 326 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.